Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
Clicks: 249
ID: 271288
2014
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
76.3
/100
248 views
201 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Aims Improving glycaemic control in people with Type 1 diabetes is known to reduce complications. Our aim was to compare glycaemic control among people with Type 1 diabetes using data gathered in regional or national registries. Methods Data were obtained for children and/or adults with Type 1 diabetes from the following countries (or regions): Western Australia, Austria, Denmark, England, Champagne‐Ardenne (France), Germany, Epirus, Thessaly and Thessaloniki (Greece), Galway (Ireland), several Italian regions, Latvia, Rotterdam (The Netherlands), Otago (New Zealand), Norway, Northern Ireland, Scotland, Sweden, Volyn (Ukraine), USA and Wales) from population or clinic‐based registries. The sample size with available data varied from 355 to 173 880. Proportions with HbA1c < 58 mmol/mol (< 7.5%) and ≥ 75 mmol/mol (≥ 9.0%) were compared by age and sex. Results Data were available for 324 501 people. The proportions with HbA1c 58 mmol/mol (< 7.5%) varied from 15.7% to 46.4% among 44 058 people aged < 15 years, from 8.9% to 49.5% among 50 766 people aged 15–24 years and from 20.5% to 53.6% among 229 677 people aged ≥ 25 years. Sex differences in glycaemic control were small. Proportions of people using insulin pumps varied between the 12 sources with data available. Conclusion These results suggest that there are substantial variations in glycaemic control among people with Type 1 diabetes between the data sources and that there is room for improvement in all populations, especially in young adults.
| Reference Key |
miller2014diabeticglycaemic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | J. A. McKnight,S. H. Wild,Maxine Lamb,Matthew Cooper,T. W. Jones,E. A. Davis,S. Hofer,Maria Fritsch,E. Schober,Jannet Svensson,T. Almdal,R. Young,J. T. Warner,B. Delemer,P. F. Souchon,R. W. Holl,W. Karges,D. M. Kieninger,Stelios Tigas,A. Bargiota,C. Sampanis,Valentino Cherubini,R. Gesuita,Ieva Strele,S. Pildava,Kirsten Coppell,G. Magee,J. G. Cooper,Sean Dinneen,K. Eeg-Olofsson,A.-M. Svensson,S. Gudbjornsdottir,H. Veeze,H.-J. Aanstoot,Mykola Khalangot,W. V. Tamborlane,K. M. Miller;J. A. McKnight;S. H. Wild;Maxine Lamb;Matthew Cooper;T. W. Jones;E. A. Davis;S. Hofer;Maria Fritsch;E. Schober;Jannet Svensson;T. Almdal;R. Young;J. T. Warner;B. Delemer;P. F. Souchon;R. W. Holl;W. Karges;D. M. Kieninger;Stelios Tigas;A. Bargiota;C. Sampanis;Valentino Cherubini;R. Gesuita;Ieva Strele;S. Pildava;Kirsten Coppell;G. Magee;J. G. Cooper;Sean Dinneen;K. Eeg-Olofsson;A.-M. Svensson;S. Gudbjornsdottir;H. Veeze;H.-J. Aanstoot;Mykola Khalangot;W. V. Tamborlane;K. M. Miller; |
| Journal | Diabetic Medicine |
| Year | 2014 |
| DOI |
10.1111/dme.12676
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.